Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of ...

In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

GLP-1 medications such as Ozempic and Wegovy, which help people lose large amounts of weight and maintain their weight loss, have been “one of the biggest cost-drivers in our system,” state ...

To understand why compounding pharmacists can make copies of semaglutide (the key ingredient in Ozempic and Wegovy ... she pointed toward an FDA warning letter against an unlicensed compounding ...

Americans spent an estimated $71.7 billion on GLP-1 drugs including Ozempic ... Wegovy in 2023, a 500 percent increase from their spending on such drugs five years earlier, according to a research ...

Wegovy (semaglutide ... Prior authorization (PA) is a form certain insurance companies require to approve your prescription for coverage. A doctor will typically submit a PA letter to an insurance ...

People who’ve been using more affordable copycat versions of Ozempic or Wegovy to lose weight will no longer have that option. “They are generally much more accessible — you can get them ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes medication Ozempic secured a court victory that limits compounding pharmacies from selling versions of those ...